-
Company Insights
Innovation and Patenting activity of Uni-President China Holdings Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Uni-President China Holdings Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UNI-50002 in Atopic Dermatitis (Atopic Eczema)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.UNI-50002 in Atopic Dermatitis (Atopic Eczema)Drug Details:Orismilast (UNI-50002 and LEO 32731) is under development for the...
-
Sector Analysis
Pasta and Noodles Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Pasta and Noodles Market Report Overview The pasta and noodles market size was estimated at $89.2 billion in 2022 and is likely to grow at a CAGR of more than 3% from 2022 to 2027. The rising health & wellness (H&W) trend among consumers, busy lifestyles, and rapid urbanization will boost the demand for convenient and easy-to-cook pasta & noodles. Pasta and Noodles Market Outlook 2022-2027 ($ Billion) Buy the Full Report for Pasta and Noodles Market Forecasts Download a...
-
Product Insights
Hypothyroidism Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Hypothyroidism Clinical Trial Report Overview The total number of Hypothyroidism clinical trials conducted as of December 2023 was 467. The Hypothyroidism clinical trial report includes information about the sponsor type and the prominent sponsors associated with the Hypothyroidism clinical trials. The report provides a comprehensive understanding of the Hypothyroidism clinical trial scenario across regions, and countries (G7 & E7), covering details on the various phases, trial status, and end points status. The Hypothyroidism clinical trials analysis report also offers exhaustive...
-
Product Insights
Choroidal Neovascularization – Drugs In Development, 2023
Global Markets Direct’s, ‘Choroidal Neovascularization - Drugs In Development, 2023’, provides an overview of the Choroidal Neovascularization pipeline landscape. The report provides comprehensive information on the therapeutics under development for Choroidal Neovascularization, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Retinal Vascular Occlusion – Drugs In Development, 2023
Global Markets Direct’s, ‘Retinal Vascular Occlusion - Drugs In Development, 2023’, provides an overview of the Retinal Vascular Occlusion pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinal Vascular Occlusion, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Retinal Vein Occlusion – Drugs In Development, 2023
Global Markets Direct’s, ‘Retinal Vein Occlusion - Drugs In Development, 2023’, provides an overview of the Retinal Vein Occlusion pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinal Vein Occlusion, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Post Menopausal Osteoporosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Drugs In Development, 2023’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post Menopausal Osteoporosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Anemia in Chronic Kidney Disease (Renal Anemia) – Drugs In Development, 2023
Global Markets Direct’s, ‘Anemia in Chronic Kidney Disease (Renal Anemia) - Drugs In Development, 2023’, provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anemia in Chronic Kidney Disease (Renal Anemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...